Literature DB >> 12046096

Clinical significance of plasma D-dimer and von Willebrand factor levels in patients with ulcer colitis.

Gang Xu1, Ke-Li Tian, Guo-Ping Liu, Xue-Jun Zhong, Shao-Ling Tang, Yan-Ping Sun.   

Abstract

AIM: To investigate the levels of D-dimer(DD) and von Willebrand factor(vWF) and the relationship between DD and vWF in ulcerative colitis(UC) patients.
METHODS: A total of 29 plasma specimens were obtained from patients with ulcerative colitis (male 13, female 16) aged 21-47 years (33+/-11). Disease activity was assessed by Truelove-Writeria. Patients with a score of above 5 were regarded as having active colitis. Twenty healthy people(male 12, female 8) aged 19-53 years(31+/-14) served as normal controls. Blood samples were taken from an antecubital vein puncture. Blood(1.8 mL) was injected into the tubes containing sodium citrate (0.13 mmol/L). The plasma was obtained by centrifugation at 3000 r.min(-1) for 10 min, and stored at -80 degrees until assayed by ELISA.
RESULTS: The mean plasma levels of DD and vWF in active UC patients were significantly higher than those of the controls (0.69+/-0.41 vs 0.27+/-0.11, P<0.01 143+/-46 vs 103+/-35, P<0.01). The mean plasma levels of DD in the patients with active disease were higher than those with inactive disease(0.69+/-0.41 vs 0.48+/-0.29 P<0.05). The levels of vWF were not different between active and inactive patients. DD levels were positively related to vWF levels( r =0.574, P<0.01). There was no significant difference between levels of DD and vWF and the scope of disease and sex of the patients.
CONCLUSION: vWF is an important feature and a good marker of UC intravascular thrombus and endothelial cell dysfunction were found in UC patients and the combined test of DD and vWF is helpful to distinguish the activity of the UC patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046096      PMCID: PMC4656447          DOI: 10.3748/wjg.v8.i3.575

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

1.  Effects of age on the performance of common diagnostic tests for pulmonary embolism.

Authors:  M Righini; C Goehring; H Bounameaux; A Perrier
Journal:  Am J Med       Date:  2000-10-01       Impact factor: 4.965

2.  Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin.

Authors:  Hui-Fei Cui; Xue-Liang Jiang
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

3.  Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; A Rumley; G D Lowe
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

4.  A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma.

Authors:  I Kohno; K Inuzuka; Y Itoh; K Nakahara; Y Eguchi; T Sugo; G Soe; Y Sakata; H Murayama; M Matsuda
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

5.  Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study.

Authors:  I Goldsmith; P Kumar; P Carter; A D Blann; R L Patel; G Y Lip
Journal:  Am Heart J       Date:  2000-11       Impact factor: 4.749

6.  ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension.

Authors:  T K Makris; G A Stavroulakis; U G Dafni; A E Gialeraki; P G Krespi; A N Hatzizacharias; C G Tsoukala; J S Vythoulkas; M K Kyriakidis
Journal:  Am Heart J       Date:  2000-11       Impact factor: 4.749

7.  Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels.

Authors:  L Albornoz; D Alvarez; J C Otaso; A Gadano; J Salviú; S Gerona; P Sorroche; A Villamil; R Mastai
Journal:  J Hepatol       Date:  1999-03       Impact factor: 25.083

8.  Serum von Willebrand factor levels in patients with inflammatory bowel disease are related to systemic inflammation.

Authors:  G Meucci; F Pareti; M Vecchi; S Saibeni; C Bressi; R de Franchis
Journal:  Scand J Gastroenterol       Date:  1999-03       Impact factor: 2.423

9.  Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study.

Authors:  A Jager; V W van Hinsbergh; P J Kostense; J J Emeis; G Nijpels; J M Dekker; R J Heine; L M Bouter; C D Stehouwer
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

10.  Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease.

Authors:  P Weber; S Husemann; H Vielhaber; K P Zimmer; U Nowak-Göttl
Journal:  J Pediatr Gastroenterol Nutr       Date:  1999-04       Impact factor: 2.839

View more
  6 in total

1.  Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation.

Authors:  Petros Zezos; Georgia Papaioannou; Nikolaos Nikolaidis; Themistoclis Vasiliadis; Olga Giouleme; Nikolaos Evgenidis
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

2.  Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis.

Authors:  Wei-Guo Dong; Shao-Ping Liu; Hai-Hang Zhu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

3.  Elevated D-dimer level in the differential diagnosis of venous malformations.

Authors:  Anne Dompmartin; Fanny Ballieux; Pascal Thibon; Agnès Lequerrec; Cédric Hermans; Philippe Clapuyt; Marie-Thérèse Barrellier; Franck Hammer; Daniel Labbé; Miikka Vikkula; Laurence M Boon
Journal:  Arch Dermatol       Date:  2009-11

4.  Relationship between plasma D-dimer levels and clinicopathologic parameters in resectable colorectal cancer patients.

Authors:  Gang Xu; Ya-Li Zhang; Wen Huang
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

5.  Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease.

Authors:  Yusuf Üstün; Serta Kilincalp; Şahin Çoban; Yusuf Coşkun; İlhami Yüksel; Aydan Ongun; İrfan Soykan; Mehmet Bektaş; Murat Törüner; Hülya Çetinkaya; Necati Örmeci
Journal:  Med Sci Monit       Date:  2016-10-24

6.  Thrombophilic Risk Factors in Patients With Inflammatory Bowel Disease.

Authors:  Ayten Yazici; Omer Senturk; Cem Aygun; Altay Celebi; Cigdem Caglayan; Sadettin Hulagu
Journal:  Gastroenterology Res       Date:  2010-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.